Methods
We studied 133 HCM patients (56±16 y, 94 men) and 120 healthy volunteers (42±13y, 60men) using 1.5T CMR scanner (Philips Achieva). Short axis slices covering the entire left ventricle were acquired using SSFP sequence to measure EF. MAPSE and TAPSE were measured in 4 chamber views. Comparable to echocardiography, two separate reference lines were drawn in diastole and systole from the basal lateral tricuspid (TAPSE) and the basal anterior mitral leaflet (MAPSE) to a reference point on the left chest surface (figure 1). P<0.05 was considered significant.
Results
Both M/TAPSE were significantly higher in volunteers compared to HCM patients (MAPSE: 14±4 mm vs. 9±5 mm; p<0.0001 and TAPSE: 20±5 mm vs. 18±8 mm; p=0.002). Left ventricular EF was significantly higher in volunteers compared to HCM patients (65±9%; vs. 62 ±10% p=0.0003). When the entire population was considered (133 patients and 120 volunteers), there was a significant correlation between MAPSE and LVEF (r =0.24, p<0.0001). There were no significant gender related differences in M/TAPSE among HCM patients or healthy volunteers. M/TAPSE did not significantly correlate with LV mass in HCM patients and did not differ in HOCM (MAPSE: 9±4 mm, TAPSE: 19±8 mm) compared to HNCM (MAPSE: 8±4 mm, TAPSE: 18±7 mm; p=ns). ANOVA analysis showed no significant differences in TAPSE, MAPSE or EF based on patients' NYHA class. Among patients, there was a significant inverse correlation between MAPSE and NT proBNP (r= -0.29, p=0.004) as well as between TAPSE and NT proBNP(r= -0.20, p=0.046).
Conclusions
We provided reference values of M/TAPSE in a large cohort of HCM patients compared to a healthy study cohort. M/TAPSE were decreased in HCM compared to healthy volunteers and were not related to obstruction in HCM. The inverse relation to NT proBNP deserves further attention regarding a possible prognostic role of these measurements in HCM. 
